Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.43 USD | +0.60% | +5.72% | -24.50% |
05-15 | Legend Expects to Log Profit in 2026 | MT |
05-14 | HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.50% | 8.23B | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- UBS Adjusts Legend Biotech's Price Target to $76 From $66, Maintains Buy Rating